- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
From Diagnostics to Cancer Drug Costs, Nothing's Off Limits at AJMCLive's Patient-Centered Oncology Care
The toughest topics in cancer care will be on tap November 13-14, 2014, in Baltimore, Maryland, when AJMCLive presents Patient-Centered Oncology Care. If you've followed the discussion among pharmaceutical leaders, oncologists, and payers over access to care, you'll want to join stakeholders to discuss how to ensure patients get what they need while controlling costs.
From Diagnostics to Cancer Drug Costs, Nothing's Off Limits at AJMCLive's Patient Centered Oncology Care
FOR IMMEDIATE RELEASEOctober 28, 2014
PLAINSBORO, N.J. — Did you see Peter Bach, MD, discussing the high cost of cancer treatment on 60 Minutes recently? Did you read about the Institute of Medicine report, Dying in America, on the widespread failure of the US healthcare system to deliver good end-of-life care?
Have you followed the growing debate between payers and pharmaceutical manufacturers over which one deserves blame when patients can’t get access to the best cancer drugs?
If you have, then you don’t want to miss “Patient-Centered Oncology Care,” the third annual multistakeholder gathering from AJMCLive, the meeting series of The American Journal of Managed Care. This year’s timely lineup, promises to be the best yet, and includes:
- Keynote addresses from Peter P. Yu, MD, the president of the American Society of Clinical Oncology (ASCO) and Burton VanderLaan, MD, medical director of PriorityHealth.
- A discussion on end-of-life care that will include Dr. Bach, breast cancer survivor Amy Berman, BS, RN, and Cardinal Health’s Bruce Feinberg, DO, and Patti Forest, MD, MBA.
- A discussion on the role of diagnostics in cancer care, reimbursement challenges and the new role of the FDA featuring Bruce Quinn, MD, PhD, of Foley Hoag; Rina Wolf of XIFIN; Howard Kaufman, MD, of Rutgers CINJ; and Joy Larsen-Haidle, MS, CGC of the National Association of Genetic Counselors.
“If there is an important topic in cancer care today, it will be aired at this meeting,” said Brian Haug, president of Managed Markets and the meeting’s host. “We are creating opportunities for everyone involved in cancer care to meet in one place, to have the dialogue that is so important to making care better for patients.”
The conference will feature representation from major national payers, sessions on accountable care organizations and patient-centered medical homes, emerging national quality standards, and more. For a full agenda, faculty lineup, and registration, visit http://www.ajmc.com/meetings/pcoc14.
The conference will take place at the Baltimore Marriott Waterfront Hotel, 700 Aliceanna St.,
Baltimore, Maryland, 21202. Hotel phone is (410) 385-3000. For staff with AJMCLive, call (609) 716-7777, x 131 or 124.
About the Journal
The American Journal of Managed Care, now in its 20th year of publication, is the leading peer-reviewed journal dedicated to issues in managed care. Other titles in the AJMC family of publications are The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision makers with information to improve the efficiency and health outcomes in managing pharmaceutical care. In December 2013, AJMC introduced The American Journal of Accountable Care, which publishes research and commentary devoted to understanding changes to the healthcare system due to the 2010 Affordable Care Act. AJMC’s news publications, the Evidence-Based series, bring together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in the areas of oncology, diabetes management, and immunology and infectious disease. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
CONTACT: Nicole Beagin (609) 716-7777 x 131
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
